In another study, researchers reviewed 114 NSM performed from 2008 to 2019 on patients with breast cancer in 105 BRCA1/2 carriers (56 BRCA1, 47 BRCA2, and two women with both mutations). This evidence concerns the gene BRCA1 and breast carcinoma.